These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1521790)

  • 1. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement.
    Devanand DP; Sackeim HA
    Gen Hosp Psychiatry; 1992 Sep; 14(5):345-9. PubMed ID: 1521790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.
    Augoustides JG; Greenblatt E; Abbas MA; O'Reardon JP; Datto CJ
    J ECT; 2002 Dec; 18(4):213-7. PubMed ID: 12468998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation.
    Hermida AP; Janjua AU; Tang Y; Syre SR; Job G; McDonald WM
    J Psychiatr Pract; 2016 Nov; 22(6):459-462. PubMed ID: 27824778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECT emergence agitation and methohexital-succinylcholine interaction. Case report.
    Swartz CM
    Gen Hosp Psychiatry; 1993 Sep; 15(5):339-41. PubMed ID: 8307349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-electroconvulsive therapy agitation with etomidate.
    Freeman SA
    J ECT; 2009 Jun; 25(2):133-4. PubMed ID: 19494736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
    Bryson EO; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2013 Jun; 29(2):e18. PubMed ID: 23519216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series.
    O'Reardon JP; Takieddine N; Datto CJ; Augoustides JG
    J ECT; 2006 Dec; 22(4):247-52. PubMed ID: 17143155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postictal excitement following bilateral and right-unilateral ECT.
    Sackeim HA; Decina P; Malitz S; Hopkins N; Yudofsky SC; Prohovnik I
    Am J Psychiatry; 1983 Oct; 140(10):1367-8. PubMed ID: 6624976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy emergence agitation and succinylcholine dose.
    Swartz CM
    J Nerv Ment Dis; 1990 Jul; 178(7):455-7. PubMed ID: 2366059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letters to the editor: Drug dosage in ECT.
    Am J Psychiatry; 1973 Nov; 130(11):1293-4. PubMed ID: 4746045
    [No Abstract]   [Full Text] [Related]  

  • 12. Postictal agitation after electroconvulsive therapy.
    Tzabazis AZ; Schmitt HJ; Muenster T
    J ECT; 2014 Sep; 30(3):e27-8. PubMed ID: 24820949
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of etomidate and methohexital as anesthetic agents for continuation and maintenance electroconvulsive therapy: A retrospective analysis of seizure quality and safety.
    Millischer V; Pramhas S; Wiedermann I; Eder V; Kress HG; Michalek-Sauberer A; Rujescu D; Frey R; Baldinger-Melich P
    J Affect Disord; 2023 Jun; 330():33-39. PubMed ID: 36863475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician.
    Cristancho MA; Alici Y; Augoustides JG; O'Reardon JP
    Curr Psychiatry Rep; 2008 Dec; 10(6):474-80. PubMed ID: 18980730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of severe postictal agitation after electroconvulsive therapy with bispectrum electroencephalogram index monitoring: a case report.
    Kranaster L; Janke C; Hoyer C; Sartorius A
    J ECT; 2012 Jun; 28(2):e9-10. PubMed ID: 22622306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of post-electroconvulsive therapy delirium and agitation with donepezil.
    Logan CJ; Stewart JT
    J ECT; 2007 Mar; 23(1):28-9. PubMed ID: 17435571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
    Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
    J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-ECT agitation and plasma lactate concentrations.
    Auriacombe M; Rénéric JP; Usandizaga D; Gomez F; Combourieu I; Tignol J
    J ECT; 2000 Sep; 16(3):263-7. PubMed ID: 11005048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postictal agitation syndrome or anxiety symptoms.
    Swartz CM
    J ECT; 2014 Sep; 30(3):e27. PubMed ID: 25144358
    [No Abstract]   [Full Text] [Related]  

  • 20. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option.
    Tzabazis A; Schmitt HJ; Ihmsen H; Schmidtlein M; Zimmermann R; Wielopolski J; Münster T
    J ECT; 2013 Sep; 29(3):189-95. PubMed ID: 23792779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.